[
  {
    "Company": "CelVivo",
    "Model": "ClinoStar 3D Culture (Liver Spheroids/Organoids)",
    "Organs/Tissues": "Liver (Hepatic Spheroids or Organoids)",
    "Physiological/Pathological": "Both (physiological function, NAFLD/fibrosis, etc.)",
    "Cell Source": "HepG2/C3A, primary hepatocytes, iPSC-derived hepatic cells",
    "Multiple Cell Types": "Usually single hepatic cell type; optional co-culture",
    "Stromal Cells": "No (base). Possible if user adds e.g. stellate/fibroblasts",
    "Tissue-resident Immune": "No (Kupffer cells not standard, must be added manually)",
    "Circulating Immune": "No (no perfusion)",
    "Crosstalk (Multi-tissue)": "No, single tissue per reactor",
    "Air-Liquid Interface": "No (submerged 3D spheroids)",
    "Extracellular Matrix": "Optional (free-floating or embedded in hydrogel)",
    "3D Scaffold": "No rigid scaffold; spheroids self-assemble",
    "Notable Features": "Long-term viability (weeks–months), near-physiological liver function (albumin, urea), disease modeling (NAFLD)",
    "Plate/Format (Throughput)": "One 10 mL ClinoReactor per culture, 6 positions in ClinoStar (low–medium throughput)",
    "Max Culture Duration": "Up to 10+ months in special cases",
    "Readouts - Live Imaging": "Yes (built-in camera for gross morphology)",
    "Readouts - Supernatant Sampling": "Yes (ports allow sampling media for liver enzymes, etc.)",
    "Readouts - Cell Retrieval": "Yes (remove spheroid for dissociation/analysis)",
    "Readouts - Whole Tissue": "Yes (histology, immunostaining on intact spheroid)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal, well-mixed 10 mL culture volume",
    "Perfused": "No (rotation-based static culture)",
    "Gas Mix Controlled": "CO₂ & O₂ via hypoxia module, remote software control",
    "Real-time Microenvironment Control": "Yes (adjust O₂ levels, rotation speed, etc. in real time)",
    "model_availability": "Offered as product-based system; user forms model in ClinoReactor"
  },
  {
    "Company": "CelVivo",
    "Model": "ClinoStar Brain Organoids",
    "Organs/Tissues": "Human brain (cortical) organoids",
    "Physiological/Pathological": "Both – normal neurodevelopment and disease (microcephaly, viral infection)",
    "Cell Source": "Pluripotent stem cells (iPSC/ESC) forming neurons/glia",
    "Multiple Cell Types": "Yes (neurons, astrocytes, other neural lineages)",
    "Stromal Cells": "N/A in brain; no fibroblasts needed",
    "Tissue-resident Immune": "Not standard (microglia can be added if desired)",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "No, single organoid per reactor",
    "Air-Liquid Interface": "No, fully submerged in medium",
    "Extracellular Matrix": "Often Matrigel at start, then free-floating organoid",
    "3D Scaffold": "Self-organized organoid, no rigid scaffold",
    "Notable Features": "Long-term neural differentiation (reduced necrosis), virus infection studies, complex layered structures",
    "Plate/Format (Throughput)": "6 reactors per ClinoStar, each can hold multiple organoids (low–medium)",
    "Max Culture Duration": "Weeks to months for neuronal maturation",
    "Readouts - Live Imaging": "Basic real-time via camera, detailed imaging requires removal",
    "Readouts - Supernatant Sampling": "Yes (cytokines, secreted factors)",
    "Readouts - Cell Retrieval": "Yes (harvest organoid for omics)",
    "Readouts - Whole Tissue": "Yes (fix & section for immunostaining)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No integrated, possible external approach",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low, 10 mL well mixed",
    "Perfused": "No, gentle rotation instead of flow",
    "Gas Mix Controlled": "CO₂/O₂ adjustable, remote software",
    "Real-time Microenvironment Control": "Yes (change rotation speed, O₂, etc.)",
    "model_availability": "Product-based (user or partner forms organoids)"
  },
  {
    "Company": "CelVivo",
    "Model": "ClinoStar Tumoroids (3D Cancer Spheroids)",
    "Organs/Tissues": "Various tumor types (lung, colon, breast, etc.)",
    "Physiological/Pathological": "Pathological cancer models; drug testing, metastasis, etc.",
    "Cell Source": "Cancer cell lines (A549, etc.), patient-derived tumor organoids (PDOs)",
    "Multiple Cell Types": "Yes, if stroma or immune cells added; commonly single tumor cell line",
    "Stromal Cells": "Not by default; user can add fibroblasts (CAFs)",
    "Tissue-resident Immune": "No, must be added if desired (e.g. macrophages)",
    "Circulating Immune": "No perfusion",
    "Crosstalk (Multi-tissue)": "No",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Optional (alginate, Matrigel) or free-floating",
    "3D Scaffold": "No built-in scaffold; spheroid typically or in hydrogel droplet",
    "Notable Features": "Long-term tumor model, drug-resistance evolution, easily adjustable O₂ for hypoxia",
    "Plate/Format (Throughput)": "One reactor per condition, 6 positions per ClinoStar (low–medium)",
    "Max Culture Duration": "Weeks–months (chronic drug exposure possible)",
    "Readouts - Live Imaging": "Yes (camera), advanced imaging requires sample removal",
    "Readouts - Supernatant Sampling": "Yes (secreted markers, lactate, etc.)",
    "Readouts - Cell Retrieval": "Yes (harvest spheroid for viability, molecular assays)",
    "Readouts - Whole Tissue": "Yes (fix for histology/IHC)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Minimal (10 mL well-mixed environment)",
    "Perfused": "No, rotation-based static culture",
    "Gas Mix Controlled": "Adjustable O₂/CO₂ (Hypoxia module)",
    "Real-time Microenvironment Control": "Yes (gas, rotation speed, repeated dosing)",
    "model_availability": "Product-based (users generate tumoroids)"
  },
  {
    "Company": "CelVivo",
    "Model": "ClinoStar Blastoid/Embryoid",
    "Organs/Tissues": "Pre-implantation embryo-like constructs (blastocysts/blastoids)",
    "Physiological/Pathological": "Primarily embryogenesis, can mimic early developmental defects",
    "Cell Source": "ESC/iPSC aggregates or actual blastomeres forming blastocyst-like spheres",
    "Multiple Cell Types": "Yes (trophectoderm, inner cell mass, possibly epiblast/hypoblast)",
    "Stromal Cells": "N/A (early embryo does not have stroma)",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "No, single embryonic structure per reactor",
    "Air-Liquid Interface": "No, submerged in medium",
    "Extracellular Matrix": "Optional minimal matrix if needed for aggregation",
    "3D Scaffold": "Self-organization, no scaffold",
    "Notable Features": "Extended culture beyond normal blastocyst stage, multi-week embryology model",
    "Plate/Format (Throughput)": "6 reactors, each can hold multiple blastoids (low throughput)",
    "Max Culture Duration": "Weeks (post-blastocyst stage)",
    "Readouts - Live Imaging": "Basic camera view, advanced imaging off-line",
    "Readouts - Supernatant Sampling": "Possible but minimal secretions",
    "Readouts - Cell Retrieval": "Yes (blastoid can be fixed/dissociated)",
    "Readouts - Whole Tissue": "Yes (immunostaining for lineage markers)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No",
    "Dead Volume": "Low in 10 mL rotating environment",
    "Perfused": "No, static rotation",
    "Gas Mix Controlled": "O₂/CO₂ set by software (5% O₂ for embryonic culture, etc.)",
    "Real-time Microenvironment Control": "Yes (gas and rotation parameters)",
    "model_availability": "Hardware product; lab forms blastoids"
  }
]
